| Ingredients | Product Name | Formulation | Report Category | Report Date |
| Pimozide | Myeongin Pimozit Tablets 4 Milligrams | Na Jeong | Supply Discontinued | 2026-02-04 |
| Cisplatin | Unistin Injection 0.5mg/ml (Cisplatin) (Export Names: Newplatin Inj. 0.5mg/ml, Cytosplat Inj. 0.5mg/ml, Nextin Inj. 0.5mg/ml, KU Cisplatin Inj. 0.5mg/ml | Solution for Injection | Supply Discontinued | 2026-02-03 |
| Nimodipine | Samjin Nimodipine Injection 10mg (Export Name: Moditoplinjection) | Solution for Injection | Supply Shortage | 2026-02-03 |
| Isosorbide Dinitrate Sustained-Release Granules | Bukwang Isosorbide Dinitrate Sustained-Release Capsules (Isosorbide Dinitrate Sustained-Release Granules) | Sustained-Release Capsule, Pellet | Supply Discontinued | 2026-02-02 |
| Polysaccharide Iron Chelate | Hemonia Capsule (Polysaccharide Iron Chelate) | Hard Capsule, Powder | Supply Discontinued | 2026-01-30 |
| Fluvastatin Sodium | Rescol XL Extended-Release Tablets (Fluvastatin Sodium) | Extended-Release Film-Coated Tablets | Supply Discontinued | 2026-01-29 |
| Haloperidol Decanoate | Haloperidol Decanoate Injection (Haloperidol Decanoate) | Solution for Injection | Supply Shortage | 2026-01-28 |
| Bacillus licheniformis, Calcium Pantothenate | Biscanbisan | Powder | Supply Discontinued | 2026-01-28 |
| Talazoparib Tosylate | Talzena Capsule 1 Milligram (Talazoparib Tosylate) | Hard Capsule, Powder | Supply Discontinued | 2026-01-28 |
| Human Papillomavirus-16 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4449), Human Papillomavirus-18 L1 (Host: Trichoplusia ni Hi-5 Rix4446, Vector: rBaculo4450) | Suvarix Prefilled Syringe [Human Papillomavirus Vaccine (Recombinant)] | Suspension for Injection | Supply Discontinued | 2026-01-23 |
| Sodium Bicarbonate | Daewon Sodium Bicarbonate Injection (8.4%) | Solution for Injection | Supply Shortage | 2026-01-22 |
| Ketorolac Tromethamine | Acuveil Eye Drops 0.45% (Ketorolac Tromethamine) (Single-Use) | Eye Drops | Supply Shortage | 2026-01-21 |
| Dilazep Hydrochloride Hydrate | Bukwang Comelian Tablets 50 milligrams (Dilazep Hydrochloride Hydrate) | Film-coated Tablet | Supply Discontinued | 2026-01-15 |
| Dacarbazine | DTIC Injection 200 Milligrams (Dacarbazine) (Export Name: DTIC-VHB for injection, Duticin for injection) | Freeze-Dried Powder for Solution for Injection | Supply Discontinued | 2026-01-15 |
| Vinblastine Sulfate | Vinblastine Sulfate Injection | Freeze-Dried Powder for Solution for Injection | Supply Discontinued | 2026-01-15 |
| Mecuitazine | Primaran Tablets (Mequitazine) | Na Jeong | Supply Discontinued | 2026-01-15 |
| Dacarbazine | DTIC Injection (Dacarbazine) (Export Name: DTIC-VHB for injection 100mg) | Freeze-Dried Powder for Solution for Injection | Supply Discontinued | 2026-01-15 |
| Deferasirox | Exzide Film-Coated Tablets 180 milligrams (Deferasirox) | Film-coated Tablet | Supply Shortage | 2026-01-14 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 10 milligrams (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Dexketoprofen Trometamol | Keral (Dexketoprofen Trometamol) | Solution for Injection | Supply Discontinued | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 20 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 40 milligrams (oxycodone hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Oxycodone Hydrochloride | OxyContin Extended-Release Tablets 80mg (Oxycodone Hydrochloride) | Extended-Release Film-Coated Tablets | Supply Shortage | 2026-01-13 |
| Nalbuphine Hydrochloride | Hanabupine Hydrochloride Injection 10mg | Solution for Injection | Supply Discontinued | 2026-01-05 |
| Nimodipine | Cerebonal Tablets (Nimodipine) | Film-coated Tablet | Supply Discontinued | 2026-01-05 |
| Active ingredients | Status | Update | Specialty |
| isoniazid, rifampicin | Supply tension | 05/02/2026 | Rifinah 300 mg/150 mg, coated tablet |
| paclitaxel | Supply tension | 05/02/2026 | Paclitaxel AHCL 6 mg/mL, solution for dilution for infusion – 50 mL and 100 mL vials |
| lenalidomide | Supply tension | 05/02/2026 | Lenalidomide Mylan, capsule |
| medroxyprogesterone | Supply tension | 04/02/2026 | Depo Prodasone 500 mg, injectable suspension |
| inchonidine (monochlorhydrate) monohydrate/cinchonine (chlorhydrate) dihydrate/quinidine (chlorhydrate) monohydrate/quinine (chlorhydrate) | Stock shortage | 03/02/2026 | Quinimax 500 mg, film-coated tablet |
| selinexor | Supply tension | 02/02/2026 | Nexpovio 20 mg, film-coated tablet |
| dulaglutide | Return to availability | 02/02/2026 | Trulicity 0.75 mg, 1.5 mg, 3 mg, 4.5 mg, injectable solution in pre-filled pen |
| ifosfamide | Supply tension | 02/02/2026 | Holoxan 1000 mg, powder for solution for injection, and 2000 mg, powder for parenteral use |
| ketoprofen | Supply tension | 02/02/2026 | Ketoprofen Pharmy II 100 mg/2 mL, intramuscular (IM) injection solution |
| gozétotide | Return to availability | 02/02/2026 | Locametz 25 micrograms, kit for radiopharmaceutical preparation |
| Active ingredients |
| Date of last message | Type of reason | AM designation | |
| Salbutamol sulfate | Initial report | 08.02.2026 | Other | Sultanol forte ready-to-use inhalation solution | |
| Isotretinoin | Change notification | 06.02.2026 | Other | ISOTRETINOIN BASICS 10 mg soft capsules | |
| Isotretinoin | Initial report | 06.02.2026 | Other | ISOTRETINOIN BASICS 20 mg soft capsules | |
| Mitomycin | Change notification | 06.02.2026 | Other | Mitem 20mg | |
| Epoetin alfa | Initial report | 06.02.2026 | Other | Epoetin alfa HEXAL 40000 IU/1 ml solution for injection in pre-filled syringe – OP6 | |
| Ivermectin | Change notification | 06.02.2026 | Other | DRIPONIN 3 mg tablets | |
| Oxcarbazepine | Change notification | 06.02.2026 | Other | Oxcarbazepine – 1 A Pharma 60 mg/ml oral suspension | |
| Pramipexole dihydrochloride monohydrate | Change notification | 06.02.2026 | Other | Pramipexole – 1 A Pharma 0.26 mg prolonged-release tablets | |
| Dexamethasone dihydrogen phosphate disodium (Ph.Eur.) | Initial report | 05.02.2026 | Other | Dexabene | |
| Ibuprofen | Change notification | 05.02.2026 | Production problem | Ibuprofen PUREN 600 mg film-coated tablets | |
| Docetaxel | Change notification | 05.02.2026 | Production problem | Docetaxel Aurobindo 20 mg/ml concentrate for solution for infusion | |
| Buprenorphine hydrochloride | Change notification | 05.02.2026 | Other | Buprenorphine PUREN 8 mg sublingual tablets | |
| Anastrozole | Change notification | 05.02.2026 | Production problem | AnastroPUREN 1 mg film-coated tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.02.2026 | Production problem | Quetiapine beta 150 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.02.2026 | Production problem | Quetiapine beta 200 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 05.02.2026 | Production problem | Quetiapine beta 300 mg prolonged-release tablets | |
| Atomoxetine hydrochloride | Change notification | 05.02.2026 | Production problem | Atomoxetine beta 18 mg hard capsules | |
| Fluoxetine hydrochloride | Change notification | 05.02.2026 | Other | Fluoxetine beta 20 | |
| Atomoxetine hydrochloride | Change notification | 05.02.2026 | Production problem | Atomoxetine beta 80 mg hard capsules | |
| Aprepitant | Change notification | 05.02.2026 | Production problem | Aprepitant beta 125 mg and 80 mg hard capsules | |
| Tacrolimus monohydrate | Initial report | 04.02.2026 | Other | Takrozem 1 mg/g ointment | |
| Lidocaine hydrochloride monohydrate | Change notification | 04.02.2026 | Other | Xylocaine Gel 2% | |
| Alprostadil | Initial report | 04.02.2026 | Other | Prostavasin 20 µg | |
| Gabapentin | Change notification | 04.02.2026 | Production problem | Gabapentin Holsten 600 mg film-coated tablets | |
| Iron(III) sodium D-gluconate hydroxide oxide complex (approx. 2:1:1:x:y) | Change notification | 04.02.2026 | Other | Ferrlecit 40 mg | |
| Risperidone | Change notification | 04.02.2026 | Production problem | Risperidone-ratiopharm 50 mg powder and solvent for the preparation of a depot injection suspension | |
| Risperidone | Change notification | 04.02.2026 | Production problem | Risperidone-ratiopharm 37.5 mg powder and solvent for the preparation of a depot injection suspension | |
| Risperidone | Change notification | 04.02.2026 | Production problem | Risperidone-ratiopharm 25 mg powder and solvent for the preparation of a depot injection suspension | |
| Candesartan cilexetil | Initial report | 03.02.2026 | Other | ATACAND 16 mg | |
| Crisantaspase | Change notification | 03.02.2026 | Other | Erwinase 10,000 IU/vial powder for the preparation of an injection/infusion solution | |
| Calcitriol | Initial report | 03.02.2026 | Other | Renatriol 0.25 µg | |
| Calcitriol | Initial report | 03.02.2026 | Other | Calcitriol KyraMed 0.25 micrograms | |
| Fluoxetine hydrochloride | Change notification | 03.02.2026 | Other | Fluoxetine Micro Labs 30 mg hard capsules | |
| Atorvastatin calcium trihydrate (Ph.Eur.) | Change notification | 03.02.2026 | Other | Atorvastatin Micro Labs 60 mg film-coated tablets | |
| Prednisolone acetate | Initial report | 03.02.2026 | Production problem | Predni-POS 0.5% | |
| Propranolol hydrochloride | Change notification | 03.02.2026 | Other | Propra-ratiopharm 10 mg film-coated tablets | |
| Methylphenidate hydrochloride | Initial report | 03.02.2026 | Other | Methylphenidate-ratiopharm 30 mg modified-release hard capsules | |
| Methylphenidate hydrochloride | Initial report | 03.02.2026 | Other | Methylphenidate-ratiopharm 20 mg modified-release hard capsules | |
| Ipratropium bromide (Ph.Eur.) | Change notification | 03.02.2026 | Production problem | Ipratropium Teva 250 micrograms/1 ml solution for nebulizer | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 03.02.2026 | Other | Quetiapine AbZ 150 mg prolonged-release tablets | |
| Quetiapine fumarate (Ph.Eur.) | Change notification | 03.02.2026 | Other | Quetiapine-ratiopharm 300 mg prolonged-release tablets | |
| Everolimus | Change notification | 03.02.2026 | Other | Everolimus-ratiopharm 5 mg tablets | |
| Everolimus | Change notification | 03.02.2026 | Other | Everolimus-ratiopharm 2.5 mg tablets | |
| Doxepine hydrochloride (Ph.Eur.) | Change notification | 03.02.2026 | Other | Doxepin-ratiopharm 25 mg film-coated tablets | |
| Alprazolam | Change notification | 03.02.2026 | Other | Alprazolam-ratiopharm 1.0 mg tablets | |
| Prednisolone acetate | Change notification | 03.02.2026 | Production problem | Predni-POS 1% | |
| Proxymetacaine hydrochloride | Change notification | 03.02.2026 | Production problem | Proparacaine-POS 0.5% | |
| Fluorometholone | Change notification | 03.02.2026 | Production problem | Fluoropos | |
| Gentamicin sulfate | Change notification | 03.02.2026 | Production problem | Gentamicin-POS | |
| Salbutamol sulfate | Change notification | 02.02.2026 | Other | Bronchospray novo |
| Active ingredients | Dosage form | Quantity of active ingredients | Shortage status | Availability | Reason | Last updated |
| prazosin hydrochloride | Tablet, uncoated | 5.476 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 9/02/2026 |
| omeprazole | Capsule, enteric | 20 mg | Current | Limited Availability | Manufacturing | 9/02/2026 |
| amlodipine besilate~atorvastatin calcium trihydrate | Tablet, film coated | 13.88 mg~86.751 mg | Current | Limited Availability | Manufacturing | 9/02/2026 |
| cabergoline | Tablet, uncoated | 1 mg | Anticipated | Available | Manufacturing | 9/02/2026 |
| atovaquone~proguanil hydrochloride | Tablet, film coated | 62.5 mg~25 mg | Resolved | Available | Unexpected increase in consumer demand | 9/02/2026 |
| salbutamol sulfate | Inhalation | 2.4 mg/mL | Current | Unavailable | Unexpected increase in demand due to other sponsors unable to supply | 6/02/2026 |
| paclitaxel | Injection, powder for | 100 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 6/02/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 555 mg | Resolved | Available | Manufacturing | 6/02/2026 |
| ciprofloxacin hydrochloride | Tablet, film coated | 832.5 mg | Current | Unavailable | Manufacturing | 6/02/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Limited Availability | Manufacturing | 6/02/2026 |
| olanzapine | Tablet, orally disintegrating | 10 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/02/2026 |
| enalapril maleate | Tablet | 5 mg | Resolved | Available | Manufacturing | 6/02/2026 |
| quetiapine fumarate | Tablet, modified release | 172.695 mg | Resolved | Available | Manufacturing | 6/02/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Current | Limited Availability | Manufacturing | 6/02/2026 |
| clindamycin hydrochloride | Capsule, hard | 162.87 mg | Anticipated | Available | Manufacturing | 6/02/2026 |
| levetiracetam | Injection, intravenous infusion | 100 mg/mL | Anticipated | Available | Manufacturing | 6/02/2026 |
| ethinylestradiol~levonorgestrel | Tablet, uncoated | 30 microgram~150 microgram | Anticipated | Available | Manufacturing | 6/02/2026 |
| citalopram hydrobromide | Tablet, film coated | 12.495 mg | Resolved | Available | Manufacturing | 6/02/2026 |
| ezetimibe | Tablet, uncoated | 10 mg | Resolved | Available | Unexpected increase in consumer demand | 6/02/2026 |
| tranexamic acid | Tablet, film coated | 500 mg | Current | Unavailable | Manufacturing | 6/02/2026 |
| hydrochlorothiazide~olmesartan medoxomil | Tablet | 12.5 mg~40 mg | Resolved | Available | Manufacturing | 6/02/2026 |
| eplerenone | Tablet, film coated | 50 mg | Anticipated | Available | Manufacturing | 6/02/2026 |
| timolol maleate~latanoprost | Eye Drops, solution | 6.83 mg/mL~.05 mg/mL | Current | Unavailable | Manufacturing | 6/02/2026 |
| midodrine hydrochloride | Tablet | 2.5 mg | Current | Unavailable | Manufacturing | 6/02/2026 |
| paclitaxel | Injection, powder for | 100 mg | Current | Limited Availability | Manufacturing | 6/02/2026 |
| lamotrigine | Tablet, chewable | 200 mg | Current | Unavailable | Manufacturing | 6/02/2026 |
| anastrozole | Tablet, film coated | 1 mg | Anticipated | Available | Manufacturing | 6/02/2026 |
| clindamycin phosphate | Cream | 22.8 mg/g | Anticipated | Available | Unexpected increase in consumer demand | 6/02/2026 |
| imipramine hydrochloride | Tablet, sugar coated | 25 mg | Current | Unavailable | Manufacturing | 6/02/2026 |
| vinorelbine tartrate | Capsule, soft | 27.7 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/02/2026 |
| vinorelbine tartrate | Capsule, soft | 41.55 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 6/02/2026 |
| ceftazidime pentahydrate | Injection, powder for | 1.164 g | Anticipated | Available | Unexpected increase in consumer demand | 5/02/2026 |
| varenicline tartrate~varenicline tartrate | Tablet, film coated | .86 mg~1.71 mg | Anticipated | Available | Manufacturing | 5/02/2026 |
| nimodipine | Tablet, film coated | 30 mg | Current | Limited Availability | Manufacturing | 5/02/2026 |
| formoterol fumarate | Inhalation, powder for | 12 microgram | Current | Limited Availability | Manufacturing | 5/02/2026 |
| glimepiride | Tablet, uncoated | 1 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| glimepiride | Tablet, uncoated | 2 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| clindamycin phosphate | Injection, solution | 0 QS | Current | Limited Availability | Manufacturing | 4/02/2026 |
| bromocriptine mesilate | Tablet, uncoated | 2.87 mg | Current | Limited Availability | Manufacturing | 4/02/2026 |
| isoniazid | Tablet, uncoated | 100 mg | Resolved | Available | Manufacturing | 4/02/2026 |
| olanzapine | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| amisulpride | Tablet | 200 mg | Anticipated | Available | Manufacturing | 4/02/2026 |
| galantamine hydrobromide | Capsule, modified release | 30.768 mg | Resolved | Available | Unexpected increase in demand due to other sponsors unable to supply | 4/02/2026 |
| lamivudine | Tablet, film coated | 100 mg | Resolved | Available | Manufacturing | 4/02/2026 |
| clevidipine | Injection, emulsion | 25 mg | Anticipated | Available | Transport / Logistic issues / Storage capacity issues | 4/02/2026 |
| gabapentin | Capsule, hard | 300 mg | Current | Limited Availability | Manufacturing | 4/02/2026 |
| fenofibrate | Tablet | 48 mg | Current | Limited Availability | Manufacturing | 4/02/2026 |
| rosuvastatin calcium | Tablet, film coated | 41.68 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| rosuvastatin calcium | Tablet, film coated | 10.42 mg | Resolved | Available | Manufacturing | 4/02/2026 |
| pregabalin | Capsule, hard | 150 mg | Current | Unavailable | Unexpected increase in consumer demand | 4/02/2026 |
| pregabalin | Capsule, hard | 75 mg | Resolved | Available | Manufacturing | 4/02/2026 |
| pregabalin | Capsule, hard | 300 mg | Resolved | Available | Manufacturing | 4/02/2026 |
| atomoxetine hydrochloride | Capsule, hard | 20.57 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| bazedoxifene acetate~conjugated estrogens | Tablet, modified release | 22.56 mg~.45 mg | Current | Unavailable | Commercial Changes / Commercial viability | 4/02/2026 |
| atorvastatin calcium trihydrate | Tablet, film coated | 43.38 mg | Current | Limited Availability | Manufacturing | 4/02/2026 |
| erenumab | Injection, solution | 70 mg | Resolved | Available | Unexpected increase in consumer demand | 4/02/2026 |
| dabigatran etexilate mesilate | Capsule, hard | 126.83 mg | Current | Limited Availability | Manufacturing | 4/02/2026 |
| posaconazole | Tablet, modified release | 100 mg | Current | Limited Availability | Manufacturing | 4/02/2026 |
| iopromide | Injection, solution | 768.86 mg/mL | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 4/02/2026 |
| progesterone | Pessary | 400 mg | Current | Emergency Supply Only | Transport / Logistic issues / Storage capacity issues | 4/02/2026 |
| metoprolol succinate | Tablet, modified release | 23.75 mg | Current | Unavailable | Unexpected increase in consumer demand | 4/02/2026 |
| methotrexate | Tablet | 2.5 mg | Anticipated | Available | Manufacturing | 4/02/2026 |
| sumatriptan succinate | Tablet, film coated | 69.99 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| naproxen | Tablet | 500 mg | Anticipated | Available | Manufacturing | 4/02/2026 |
| aripiprazole monohydrate | Injection, powder for | 416.07 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| olanzapine | Tablet, film coated | 2.5 mg | Current | Limited Availability | Manufacturing | 4/02/2026 |
| ethinylestradiol~norethisterone | Tablet, uncoated | 36 microgram~500 microgram | Current | Limited Availability | Manufacturing | 4/02/2026 |
| raloxifene hydrochloride | Tablet, film coated | 60 mg | Anticipated | Available | Manufacturing | 4/02/2026 |
| olanzapine | Wafer | 5 mg | Resolved | Available | Transport / Logistic issues / Storage capacity issues | 4/02/2026 |
| ampicillin | Injection, powder for | 500 mg | Anticipated | Available | Unexpected increase in consumer demand | 4/02/2026 |
| lamotrigine | Tablet, dispersible | 100 mg | Current | Unavailable | Manufacturing | 4/02/2026 |
| gabapentin | Capsule, hard | 400 mg | Current | Unavailable | Manufacturing | 3/02/2026 |
| imipramine hydrochloride | Tablet, sugar coated | 10 mg | Anticipated | Available | Manufacturing | 3/02/2026 |
| bupivacaine hydrochloride | Injection, solution | 5 mg/mL | Resolved | Available | Manufacturing | 3/02/2026 |
| adenosine | Injection, solution | 6 mg | Anticipated | Available | Manufacturing | 3/02/2026 |
| galantamine hydrobromide | Capsule, modified release | 10.256 mg | Anticipated | Available | Unexpected increase in demand due to other sponsors unable to supply | 3/02/2026 |
| letrozole | Tablet, film coated | 2.5 mg | Resolved | Available | Manufacturing | 3/02/2026 |
| Somatropin | Injection, powder for | 5 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 3/02/2026 |
| lamivudine | Tablet, film coated | 300 mg | Current | Unavailable | Manufacturing | 3/02/2026 |
| rocuronium bromide | Injection, solution | 50 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| temozolomide | Capsule, hard | 140 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| valsartan~hydrochlorothiazide | Tablet, film coated | 160 mg~12.5 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| quetiapine fumarate | Tablet, modified release | 172.695 mg | Anticipated | Available | Manufacturing | 3/02/2026 |
| quetiapine fumarate | Tablet, modified release | 57.565 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| linezolid | Tablet, film coated | 600 mg | Resolved | Available | Manufacturing | 3/02/2026 |
| crisaborole | Ointment | 2 % w/w | Anticipated | Available | Unexpected increase in consumer demand | 3/02/2026 |
| doxepin hydrochloride | Capsule, hard | 11.3 mg | Current | Unavailable | Manufacturing | 3/02/2026 |
| deferasirox | Tablet, film coated | 90 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| deferasirox | Tablet, film coated | 360 mg | Current | Unavailable | Manufacturing | 3/02/2026 |
| escitalopram oxalate | Tablet, film coated | 25.548 mg | Resolved | Available | Manufacturing | 3/02/2026 |
| enoxaparin sodium | Injection, solution | 100 mg | Discontinued | Reduction in supply until supply is exhausted | Commercial Changes / Commercial viability | 3/02/2026 |
| rimegepant sulfate | Tablet, orally disintegrating | 85.65 mg | Resolved | Available | Manufacturing | 3/02/2026 |
| daunorubicin hydrochloride | Injection, powder for | 20 mg | Anticipated | Available | Manufacturing | 3/02/2026 |
| tamoxifen citrate | Tablet, uncoated | 15.2 mg | Current | Unavailable | Manufacturing | 3/02/2026 |
| tamoxifen citrate | Tablet, uncoated | 30.4 mg | Current | Unavailable | Manufacturing | 3/02/2026 |
| vancomycin hydrochloride | Injection, powder for | 1000 mg | Anticipated | Available | Manufacturing | 3/02/2026 |
| gramicidin~framycetin sulfate~dexamethasone | Ear Drops | .05 mg/mL~5 mg/mL~.5 mg/mL | Current | Limited Availability | Manufacturing | 3/02/2026 |
| levodopa~carbidopa monohydrate | Tablet, uncoated | 100 mg~26.9 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| parecoxib sodium | Injection, powder for | 42.36 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| nizatidine | Capsule | 300 mg | Current | Limited Availability | Manufacturing | 3/02/2026 |
| lamotrigine | Tablet, dispersible | 200 mg | Current | Unavailable | Manufacturing | 3/02/2026 |
| oxycodone hydrochloride | Tablet, uncoated | 5 mg | Current | Limited Availability | Manufacturing | 2/02/2026 |
| phenylephrine hydrochloride~prednisolone acetate | Eye Drops, suspension | 1.2 mg/mL~10 mg/mL | Current | Limited Availability | Unexpected increase in consumer demand | 2/02/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 60 mg | Current | Limited Availability | Manufacturing | 2/02/2026 |
| ibuprofen | Injection, solution | 5 mg/mL | Current | Unavailable | Unexpected increase in consumer demand | 2/02/2026 |
| betahistine dihydrochloride | Tablet, uncoated | 16 mg | Current | Limited Availability | Unexpected increase in demand due to other sponsors unable to supply | 2/02/2026 |
| oseltamivir phosphate | Capsule, hard | 98.5 mg | Resolved | Available | Unexpected increase in consumer demand | 2/02/2026 |
| gliclazide | Tablet, uncoated | 80 mg | Anticipated | Available | Manufacturing | 2/02/2026 |
| escitalopram oxalate | Tablet, film coated | 12.774 mg | Anticipated | Available | Manufacturing | 2/02/2026 |
| ondansetron hydrochloride dihydrate | Tablet, film coated | 4.986 mg | Resolved | Available | Manufacturing | 2/02/2026 |
| lamotrigine | Tablet | 100 mg | Current | Unavailable | Manufacturing | 2/02/2026 |
| labetalol hydrochloride | Tablet, film coated | 200 mg | Anticipated | Available | Manufacturing | 2/02/2026 |
| methylphenidate hydrochloride | Capsule, modified release | 40 mg | Current | Limited Availability | Manufacturing | 2/02/2026 |
| simvastatin | Tablet, film coated | 5 mg | Current | Unavailable | Manufacturing | 2/02/2026 |
| Generic Name | Shortage Status | Revision Date |
| Disopyramide Phosphate Controlled-Release Capsules | Current Shortages | 5-Feb-26 |
| Acetaminophen Injection | Current Shortages | 4-Feb-26 |
| Acetazolamide Injection | Current Shortages | 4-Feb-26 |
| Ascorbic Acid Injection | Current Shortages | 4-Feb-26 |
| Budesonide Suspension for Inhalation | Current Shortages | 4-Feb-26 |
| Cisplatin Injection | Current Shortages | 4-Feb-26 |
| Dexamethasone Sodium Phosphate Injection | Current Shortages | 4-Feb-26 |
| Fentanyl Citrate Injection | Current Shortages | 4-Feb-26 |
| Hydromorphone Hydrochloride Injection | Current Shortages | 4-Feb-26 |
| Hydroxyethyl Starch (Hetastarch) | Current Shortages | 4-Feb-26 |
| Leucovorin Calcium Injection | Current Shortages | 4-Feb-26 |
| Penicillin G Benzathine / Penicillin G Procaine | Current Shortages | 4-Feb-26 |
| Desmopressin Acetate Nasal Spray | Current Shortages | 3-Feb-26 |
| Dicyclomine Oral Presentations | Current Shortages | 3-Feb-26 |
| Epinephrine Auto-Injectors | Current Shortages | 3-Feb-26 |
| Peginterferon Alfa-2a Injection | Current Shortages | 3-Feb-26 |
February 03, 2026
February 06, 2026
February 05, 2026
February 04, 2026
February 03, 2026
February 02, 2026
